Altimmune (ALT) Treasury Shares (2010 - 2026)

Altimmune (ALT) has 15 years of Treasury Shares data on file, last reported at $2.2 million in Q1 2026.

• On a quarterly basis, Treasury Shares rose 105.06% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $2.2 million, a 105.06% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, up 140.45% from the prior year.
• Treasury Shares for Q1 2026 stood at $2.2 million, up from $2.1 million in the prior quarter.
• Over the last five years, Treasury Shares for ALT reached as high as $2.2 million in Q1 2026 and fell as low as $414485.0 in Q4 2022.
• Historically, Treasury Shares has averaged $885956.3 across 5 years, with a median of $784227.0 in 2024.
• Across the five-year window, Treasury Shares surged 460.11% in 2022 and rose 16.65% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $414485.0 in 2022, then soared by 45.76% to $604167.0 in 2023, then surged by 42.06% to $858290.0 in 2024, then jumped by 140.45% to $2.1 million in 2025, then gained by 4.66% to $2.2 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $2.2 million in Q1 2026, $2.1 million in Q4 2025, and $1.1 million in Q3 2025.